Skip to content

Comparing Levobupivacaine 0.25% and Ropivacaine 0.25% for caudal epidural anaesthesia for infra umbilical surgeries in children

Comparison of Levobupivacaine 0.25% and Ropivacaine 0.25% for caudal epidural anaesthesia in children undergoing infra umbilical surgeries - a randomised clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064524
Enrollment
92
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Levobupivacaine: Patient will recieve 1ml per kg body weight of 0.25% of Levobupivacaine for caudal epidural anaesthesia and observe for every 5 minutes till 60 minutes Control Interven

Sponsors

Dr Manchikanti V D Avinash
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA 1 AND 2 2.Patients undergoing elective infraumbilical surgeries 3.Parental consent 4.Duration of surgery less than 1 hour

Exclusion criteria

Exclusion criteria: 1.Patients who are allergic to local anaesthetics 2. Patients with coagulation abnormalities 3.Patients with spinal abnormalities and neurological deficits. 4. Patients with infection at the site of block

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of analgesia and drug with less toxic effect of 0.25% Levobupivacaine and 0.25% Ropivacaine in Paediatric patients undergoing infra umbilical surgeries under caudal epidural anaesthesia.Timepoint: 5,10,15,20,25,30,35,40,45,50,55 and 60 minutes

Secondary

MeasureTime frame
Duration of post operative analgesia and complications if anyTimepoint: 5,10,15,20,25,30,35,40,45,50,55 and 60 minutes

Countries

India

Contacts

Public ContactDr Manjunath c Patil

Jawaharlal Nehru Medical College

mcpatil52@rediffmail.com9743110637

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026